William Freed-Pastor

William Freed-Pastor

Company: Dana-Farber Cancer Institute & Harvard Medical School

Job title: Instructor of Medicine


Revealing How the CD155/TIGIT Axis Plays a Critical Role in Pancreatic Cancer Immune Evasion 9:30 am

• Novel preclinical models of neoantigen-expressing pancreas cancer uncover a key role for CD155/TIGIT • CD155/TIGIT axis is sufficient to mediate immune evasion in PDAC • TIGIT/PD-1 co-blockade plus CD40 agonism elicits robust anti-tumor activity in PDAC preclinical modelsRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.